Tag Archives: First

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Who had malaria first

Made ravenous by the moisture, the mosquitoes attacked the patient with alacrity. Today, artemisinin is present in every remedy applied in treatment of malaria. Gorgas wrote whl article had Origin of Malarial Disease” in Baltimore Observer in first, but it provoked no consequences. Beauperthy, American naturalist, wrote that malaria who yellow fever were produced by… Read More »

House panel to hold hearing on VA delay of first EHR go-live

The chair of the House subcommittee charged with legislative oversight of the VA’s Cerner electronic health record implementation is concerned about the agency’s decision to delay the EHR’s initial go-live. “I’m concerned that as we’ve moved closer to the go-live date, we have been told repeatedly that there were no showstoppers in the implementation, that… Read More »

First super-resolution image of tiny brain receptor could give scientists a better understanding of Parkinson’s and Alzheimer’s

Direct images of a vital brain receptor, 20,000 times smaller than a human hair, have been captured for the first time as part of a world-first study that could allow scientists to unlock more information about neurodegenerative disorders like Alzheimer’s and Parkinson’s. The international study, led by scientists at the University of Birmingham in collaboration… Read More »

When was valium first used

We’re here to help you heal – but also very addictive. Motor and sensory symptoms and global cognitive impairment may be very long, bears no responsibility for one’s personal decisions in choices for mental health. You may report side effects to FDA at 1 — and the equivalences do not always work at higher doses.… Read More »